This webinar addresses new translational workflows to support proteomic profiling for biomarker discovery through precision medicine.
Recent advances in mass spectrometry have expanded the opportunities for translational proteomics, which complements other omics disciplines such as genomics, transcriptomics, and metabolomics/lipidomics. However, a key challenge is bridging the gap between early-stage discovery and next-stage, routine quantitative application of biomarker assays in the clinical research setting.
To accelerate the discovery of clinically actionable biomarkers, workflow solutions need to address scalability, reproducibility, and robustness. They also need to support the analysis of larger patient cohorts.
Our first speaker, Emily Chen, senior director of the Thermo Fisher Precision Science Center, discusses the need to achieve precision proteomics as a first step toward achieving precision medicine. She presents precision medicine workflows that focus on biofluids and FFPE tissues and applications using these workflows.
Our second speaker, Nicolai Bache, head of applications at Evosep, discusses a new low-flow separation system for proteomics-based translational research.
More information on other webinars in this series can be found here.